| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mycobacterium avium-intracellulare Infection | 6 | 2018 | 59 | 1.06 | Why? |
| Mycobacterium Infections, Nontuberculous | 6 | 2018 | 167 | 0.86 | Why? |
| Arcuate Nucleus of Hypothalamus | 1 | 2019 | 5 | 0.84 | Why? |
| Calcium Channels, L-Type | 1 | 2019 | 15 | 0.83 | Why? |
| Neuropeptide Y | 1 | 2019 | 14 | 0.83 | Why? |
| Apolipoproteins B | 1 | 2019 | 47 | 0.80 | Why? |
| Amyloid beta-Peptides | 1 | 2019 | 185 | 0.70 | Why? |
| Hypercalcemia | 1 | 2017 | 40 | 0.67 | Why? |
| Adrenal Insufficiency | 1 | 2017 | 190 | 0.54 | Why? |
| Calcium | 1 | 2019 | 708 | 0.54 | Why? |
| Mycobacterium avium Complex | 6 | 2018 | 61 | 0.54 | Why? |
| Endocrine System Diseases | 1 | 2017 | 282 | 0.51 | Why? |
| Neurons | 1 | 2019 | 864 | 0.50 | Why? |
| Alzheimer Disease | 2 | 2019 | 1020 | 0.48 | Why? |
| Lung Diseases | 7 | 2018 | 2361 | 0.41 | Why? |
| Diabetic Ketoacidosis | 1 | 2017 | 622 | 0.39 | Why? |
| Peptide Fragments | 1 | 2019 | 2075 | 0.37 | Why? |
| Pneumonia, Pneumococcal | 2 | 2018 | 251 | 0.28 | Why? |
| Lung | 15 | 2020 | 31049 | 0.25 | Why? |
| Nontuberculous Mycobacteria | 3 | 2017 | 114 | 0.24 | Why? |
| Emergencies | 1 | 2017 | 4095 | 0.23 | Why? |
| Japan | 9 | 2021 | 6653 | 0.22 | Why? |
| Orthomyxoviridae Infections | 2 | 2019 | 1001 | 0.22 | Why? |
| Membrane Potentials | 1 | 2019 | 56 | 0.21 | Why? |
| Ghrelin | 1 | 2019 | 22 | 0.21 | Why? |
| Pneumonia, Bacterial | 2 | 2018 | 843 | 0.20 | Why? |
| Still's Disease, Adult-Onset | 1 | 2021 | 100 | 0.20 | Why? |
| RANK Ligand | 1 | 2019 | 47 | 0.20 | Why? |
| ACTH Syndrome, Ectopic | 1 | 2018 | 2 | 0.19 | Why? |
| Back Muscles | 1 | 2018 | 11 | 0.19 | Why? |
| Esthesioneuroblastoma, Olfactory | 1 | 2018 | 13 | 0.19 | Why? |
| Receptors, Lysosphingolipid | 1 | 2018 | 25 | 0.19 | Why? |
| Lactates | 1 | 2019 | 59 | 0.19 | Why? |
| Gastrointestinal Hormones | 1 | 2018 | 7 | 0.19 | Why? |
| Caloric Restriction | 1 | 2019 | 56 | 0.19 | Why? |
| Mycobacterium fortuitum | 1 | 2018 | 4 | 0.19 | Why? |
| Nocardia Infections | 1 | 2018 | 37 | 0.18 | Why? |
| Lipoproteins, LDL | 1 | 2019 | 115 | 0.18 | Why? |
| Dermatomyositis | 1 | 2021 | 193 | 0.18 | Why? |
| Adult Stem Cells | 1 | 2018 | 68 | 0.18 | Why? |
| Antibodies, Fungal | 1 | 2018 | 49 | 0.18 | Why? |
| Naphthalenes | 1 | 2018 | 94 | 0.18 | Why? |
| Thyroid Crisis | 1 | 2017 | 5 | 0.18 | Why? |
| Respiratory Function Tests | 4 | 2018 | 1755 | 0.18 | Why? |
| Culture Media, Conditioned | 2 | 2018 | 66 | 0.18 | Why? |
| Aldehyde Dehydrogenase, Mitochondrial | 1 | 2017 | 10 | 0.18 | Why? |
| Tuberculosis, Pulmonary | 2 | 2018 | 1171 | 0.18 | Why? |
| Diet, High-Fat | 1 | 2018 | 161 | 0.17 | Why? |
| Amikacin | 1 | 2017 | 62 | 0.17 | Why? |
| Neuropeptides | 1 | 2018 | 91 | 0.17 | Why? |
| Clarithromycin | 1 | 2018 | 112 | 0.17 | Why? |
| Pulmonary Emphysema | 1 | 2018 | 122 | 0.17 | Why? |
| Prednisolone | 1 | 2020 | 443 | 0.16 | Why? |
| Small Cell Lung Carcinoma | 1 | 2018 | 133 | 0.16 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.16 | Why? |
| Bronchiectasis | 2 | 2018 | 312 | 0.16 | Why? |
| STAT3 Transcription Factor | 1 | 2018 | 268 | 0.16 | Why? |
| Cholesterol, HDL | 1 | 2019 | 439 | 0.15 | Why? |
| Cryptococcosis | 1 | 2017 | 97 | 0.15 | Why? |
| Streptococcus pneumoniae | 2 | 2018 | 827 | 0.15 | Why? |
| Lung Diseases, Fungal | 1 | 2017 | 167 | 0.15 | Why? |
| Immunity, Mucosal | 1 | 2019 | 426 | 0.15 | Why? |
| Homeostasis | 1 | 2019 | 582 | 0.15 | Why? |
| Walk Test | 1 | 2018 | 461 | 0.15 | Why? |
| Mice, Transgenic | 2 | 2019 | 2739 | 0.15 | Why? |
| Cholesterol | 1 | 2019 | 660 | 0.14 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.14 | Why? |
| Quality of Life | 5 | 2018 | 9820 | 0.14 | Why? |
| Antiphospholipid Syndrome | 1 | 2020 | 533 | 0.13 | Why? |
| Pneumonectomy | 1 | 2017 | 278 | 0.13 | Why? |
| Toll-Like Receptor 8 | 1 | 2013 | 102 | 0.13 | Why? |
| Aging | 3 | 2019 | 3581 | 0.13 | Why? |
| Pseudomonas Infections | 1 | 2017 | 425 | 0.12 | Why? |
| Arthritis | 1 | 2017 | 288 | 0.12 | Why? |
| Stem Cells | 1 | 2019 | 595 | 0.12 | Why? |
| Tomography, X-Ray Computed | 12 | 2020 | 25144 | 0.12 | Why? |
| Interferon-beta | 1 | 2019 | 979 | 0.12 | Why? |
| Mice, Inbred C57BL | 6 | 2019 | 5542 | 0.12 | Why? |
| Pulmonary Aspergillosis | 1 | 2018 | 408 | 0.12 | Why? |
| Azetidines | 1 | 2018 | 722 | 0.12 | Why? |
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2020 | 645 | 0.11 | Why? |
| Adenocarcinoma | 1 | 2018 | 651 | 0.11 | Why? |
| Mitochondria | 1 | 2019 | 857 | 0.11 | Why? |
| Opportunistic Infections | 1 | 2018 | 602 | 0.11 | Why? |
| Lung Neoplasms | 2 | 2018 | 3228 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Respiratory Tract Diseases | 1 | 2019 | 1061 | 0.11 | Why? |
| Interferon-alpha | 1 | 2019 | 1442 | 0.11 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 595 | 0.11 | Why? |
| Pulmonary Fibrosis | 1 | 2020 | 1068 | 0.10 | Why? |
| Respiratory Mucosa | 1 | 2019 | 1522 | 0.10 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.10 | Why? |
| Toll-Like Receptor 7 | 1 | 2013 | 402 | 0.10 | Why? |
| Indoles | 1 | 2017 | 1243 | 0.10 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2020 | 1380 | 0.09 | Why? |
| CD11b Antigen | 2 | 2018 | 90 | 0.09 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.09 | Why? |
| Mice | 8 | 2019 | 21357 | 0.09 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.09 | Why? |
| Colitis, Ulcerative | 1 | 2017 | 1037 | 0.08 | Why? |
| Feeding Behavior | 1 | 2019 | 1909 | 0.08 | Why? |
| Lung Diseases, Interstitial | 1 | 2017 | 1476 | 0.08 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 1322 | 0.08 | Why? |
| Female | 23 | 2021 | 380317 | 0.08 | Why? |
| Animals | 10 | 2019 | 78931 | 0.07 | Why? |
| Macrophages | 2 | 2018 | 2784 | 0.07 | Why? |
| Male | 25 | 2021 | 367725 | 0.07 | Why? |
| Vital Capacity | 2 | 2017 | 399 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.07 | Why? |
| Membrane Glycoproteins | 1 | 2013 | 2273 | 0.07 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 2984 | 0.07 | Why? |
| Anti-Bacterial Agents | 4 | 2018 | 10083 | 0.07 | Why? |
| Humans | 32 | 2021 | 930598 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.06 | Why? |
| Aged | 16 | 2021 | 215776 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| Recurrence | 3 | 2018 | 3675 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.06 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Ligands | 2 | 2018 | 1300 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2018 | 6670 | 0.05 | Why? |
| Cell Proliferation | 2 | 2018 | 1973 | 0.05 | Why? |
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2019 | 13 | 0.05 | Why? |
| Tumor Necrosis Factors | 1 | 2019 | 28 | 0.05 | Why? |
| Bronchioles | 1 | 2019 | 33 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 245 | 0.05 | Why? |
| Nocardia | 1 | 2018 | 21 | 0.05 | Why? |
| Sputum | 2 | 2018 | 1720 | 0.05 | Why? |
| Simplified Acute Physiology Score | 1 | 2019 | 102 | 0.05 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.05 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.05 | Why? |
| Emphysema | 1 | 2019 | 52 | 0.05 | Why? |
| Lymphoid Tissue | 1 | 2019 | 162 | 0.05 | Why? |
| Nose Neoplasms | 1 | 2018 | 43 | 0.05 | Why? |
| Obesity | 1 | 2019 | 7388 | 0.04 | Why? |
| GPI-Linked Proteins | 1 | 2019 | 317 | 0.04 | Why? |
| Residual Volume | 1 | 2017 | 45 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Lymphadenitis | 1 | 2017 | 53 | 0.04 | Why? |
| Total Lung Capacity | 1 | 2017 | 40 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2019 | 5440 | 0.04 | Why? |
| Adoptive Transfer | 1 | 2018 | 250 | 0.04 | Why? |
| Reproducibility of Results | 3 | 2020 | 11304 | 0.04 | Why? |
| Perfusion Imaging | 1 | 2018 | 199 | 0.04 | Why? |
| Disease Models, Animal | 3 | 2019 | 10998 | 0.04 | Why? |
| Gastroesophageal Reflux | 1 | 2018 | 124 | 0.04 | Why? |
| APACHE | 1 | 2019 | 682 | 0.04 | Why? |
| Pulmonary Circulation | 1 | 2018 | 207 | 0.04 | Why? |
| Gastrectomy | 1 | 2018 | 225 | 0.04 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.04 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.04 | Why? |
| Phagocytosis | 1 | 2018 | 409 | 0.04 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.04 | Why? |
| Mycobacterium | 1 | 2017 | 143 | 0.04 | Why? |
| Cytokines | 2 | 2018 | 15010 | 0.04 | Why? |
| Cigarette Smoking | 1 | 2019 | 337 | 0.04 | Why? |
| Toll-Like Receptors | 1 | 2018 | 365 | 0.04 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2017 | 2483 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2018 | 632 | 0.04 | Why? |
| Macrophages, Alveolar | 1 | 2019 | 668 | 0.04 | Why? |
| Medical Records | 1 | 2017 | 513 | 0.04 | Why? |
| Hospital Mortality | 1 | 2019 | 22087 | 0.03 | Why? |
| Cell Culture Techniques | 1 | 2019 | 704 | 0.03 | Why? |
| Cell Movement | 1 | 2018 | 695 | 0.03 | Why? |
| Transplantation, Homologous | 1 | 2017 | 757 | 0.03 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.03 | Why? |
| Spirometry | 1 | 2017 | 524 | 0.03 | Why? |
| Receptors, Cell Surface | 1 | 2018 | 586 | 0.03 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.03 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 92 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Trachea | 1 | 2019 | 894 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Transcription Factor RelA | 1 | 2013 | 122 | 0.03 | Why? |
| Lipopolysaccharides | 1 | 2018 | 848 | 0.03 | Why? |
| Glucocorticoids | 2 | 2020 | 4431 | 0.03 | Why? |
| Cell Survival | 1 | 2019 | 1581 | 0.03 | Why? |
| Methotrexate | 1 | 2017 | 471 | 0.03 | Why? |
| Myeloid Cells | 1 | 2018 | 808 | 0.03 | Why? |
| Pneumococcal Infections | 1 | 2019 | 562 | 0.03 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.03 | Why? |
| Infliximab | 1 | 2017 | 502 | 0.03 | Why? |
| Bone Marrow Cells | 1 | 2013 | 186 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.03 | Why? |
| Radiography, Thoracic | 2 | 2018 | 5486 | 0.03 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 2309 | 0.03 | Why? |
| Signal Transduction | 2 | 2019 | 7207 | 0.02 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.02 | Why? |
| Orthomyxoviridae | 1 | 2018 | 1168 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2019 | 5814 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Fatal Outcome | 1 | 2017 | 3438 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Thorax | 1 | 2017 | 1873 | 0.02 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Interleukin-10 | 1 | 2013 | 1409 | 0.02 | Why? |
| Epithelial Cells | 1 | 2019 | 3508 | 0.02 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2018 | 53120 | 0.02 | Why? |
| NF-kappa B | 1 | 2013 | 1301 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| RNA Viruses | 1 | 2013 | 824 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Cough | 1 | 2017 | 4891 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.01 | Why? |
| Gene Expression Regulation | 1 | 2013 | 4020 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.01 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 7868 | 0.01 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Immunologic Factors | 1 | 2013 | 4206 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Interleukin-6 | 1 | 2013 | 7522 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2019 | 22116 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Intensive Care Units | 1 | 2019 | 29594 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |